- Home
- ISPC vs SBFM Comparison
ISPC vs SBFM Comparison
Compare ISPC & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ISPC | SBFM |
|---|---|---|
| Founded | 2009 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Precision Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2M | 2.2M |
| IPO Year | 2020 | 2008 |
Fundamental Metrics
Financial Performance| Metric | ISPC | SBFM |
|---|---|---|
| Price | $0.81 | $2.75 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 94.4K | ★ 2.2M |
| Earning Date | 11-20-2026 | 11-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 87.03 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $1,928,998.00 | ★ $36,305,891.00 |
| Revenue This Year | $638.10 | $1.23 |
| Revenue Next Year | $17.50 | $22.44 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 4.11 |
| 52 Week Low | $0.75 | $0.13 |
| 52 Week High | $115.00 | $17.90 |
Technical Indicators
Market Signals| Indicator | ISPC | SBFM |
|---|---|---|
| Relative Strength Index (RSI) | 32.46 | 70.14 |
| Support Level | $0.75 | $1.06 |
| Resistance Level | $1.15 | $3.25 |
| Average True Range (ATR) | 0.09 | 0.28 |
| MACD | 0.01 | 0.13 |
| Stochastic Oscillator | 23.89 | 78.77 |
Price Performance
Historical ComparisonAbout ISPC iSpecimen Inc.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas, Europe, the Middle East, Africa, and the Asia Pacific, with the majority coming from the Americas. The Company has one reportable segment: biospecimens.
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.